Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases

被引：0

作者：

Ashwell, Susan ^{[1
]}

Caleb, Benjamin L. ^{[1
]}

Deng, Chun ^{[1
]}

Green, Stephen ^{[2
]}

Grondine, Michael R. ^{[1
]}

Haye, Heather R. ^{[2
]}

Horn, Candice L. ^{[1
]}

Janetka, James W.

Liu, Dongfang ^{[1
]}

Mouchet, Elizabeth ^{[2
]}

Ready, Shannon ^{[1
]}

Rosenthal, Judith L. ^{[1
]}

Queva, Christophe ^{[1
]}

Taylor, Karen J. ^{[2
]}

Sheehy, Adam M. ^{[1
]}

Walker, Graeme E. ^{[2
]}

White, Anne M. ^{[2
]}

Zabludoff, Sonya D. ^{[1
]}

机构：

[1] AstraZeneca, Waltham, MA USA

[2] AstraZeneca, Macclesfield, Cheshire, England

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3411S / 3411S

页数：1

共 50 条

[41] Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3
Noori, Mahboubeh S.
Bhatt, Pooja M.
Courreges, Maria C.
Ghazanfari, Davoud
Cuckler, Chaz
Orac, Crina M.
McMills, Mark C.
Schwartz, Frank L.
Deosarkar, Sudhir P.
Bergmeier, Stephen C.
McCall, Kelly D.
Goetz, Douglas J.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2019, 317 (06): : C1289 - C1303
[42] AZD4625 is a Potent and Selective Inhibitor of KRASG12C
Chakraborty, Atanu
Hanson, Lyndsey
Robinson, David
Lewis, Hilary
Bickerton, Sue
Davies, Michael
Polanski, Radoslaw
Whiteley, Rebecca
Koers, Alex
Atkinson, James
Baker, Tamara
Barrantes, Ivan del Barco
Ciotta, Giovanni
Kettle, Jason G.
Magiera, Lukasz
Martins, Carla P.
Peter, Alison
Wigmore, Eleanor
Underwood, Zoe
Cosulich, Sabina
Niedbala, Michael
Ross, Sarah
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (10) : 1535 - 1546
[43] IDENTIFICATION AND CHARACTERIZATION OF A POTENT, SELECTIVE KATII INHIBITOR
Strick, Christine
Campbell, B.
Culp, J.
Dounay, A.
Fonseca, K.
Hawrylik, S.
Hayward, M.
Horner, W.
Hughes, Z.
James, Larry
Loulakis, P.
McGinnis, D.
Salafia, M.
Seymour, P.
Sneed, B.
Stratman, N.
Stutzman-Engwall, K.
Valentine, J.
Verhoest, P.
Wang, H.
Zawadzke, L.
Zhao, H.
SCHIZOPHRENIA BULLETIN, 2011, 37 : 113 - 114
[44] AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Keeton, Erika K.
McEachern, Kristen
Dillman, Keith S.
Palakurthi, Sangeetha
Cao, Yichen
Grondine, Michael R.
Kaur, Surinder
Wang, Suping
Chen, Yuching
Wu, Allan
Shen, Minhui
Gibbons, Francis D.
Lamb, Michelle L.
Zheng, Xiaolan
Stone, Richard M.
DeAngelo, Daniel J.
Platanias, Leonidas C.
Dakin, Les A.
Chen, Huawei
Lyne, Paul D.
Huszar, Dennis
BLOOD, 2014, 123 (06) : 905 - 913
[45] Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
Oza, Vibha
Ashwell, Susan
Almeida, Lynsie
Brassil, Patrick
Breed, Jason
Deng, Chun
Gero, Thomas
Grondine, Michael
Horn, Candice
Ioannidis, Stephanos
Liu, Dongfang
Lyne, Paul
Newcombe, Nicholas
Pass, Martin
Read, Jon
Ready, Shannon
Rowsell, Sian
Su, Mei
Toader, Dorin
Vasbinder, Melissa
Yu, Dingwei
Yu, Yan
Xue, Yafeng
Zabludoff, Sonya
Janetka, James
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5130 - 5142
[46] Efficacy and Mechanism of Action of Volasertib, a Potent and Selective Inhibitor of Polo-Like Kinases, in Preclinical Models of Acute Myeloid Leukemia
Rudolph, Dorothea
Impagnatiello, Maria Antonietta
Blaukopf, Claudia
Sommer, Christoph
Gerlich, Daniel W.
Roth, Mareike
Tontsch-Grunt, Ulrike
Wernitznig, Andreas
Savarese, Fabio
Hofmann, Marco H.
Albrecht, Christoph
Geiselmann, Lena
Reschke, Markus
Garin-Chesa, Pilar
Zuber, Johannes
Moll, Juergen
Adolf, Guenther R.
Kraut, Norbert
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (03): : 579 - 589
[47] A novel, potent inhibitor of Src family kinases with in vivo activity
Boschelli, Frank
Golas, Jennifer M.
Golas, Jonathan
Lucas, Judy
Discafani, Carolyn
Arndt, Kim
Boschelli, Diane
CANCER RESEARCH, 2006, 66 (08)
[48] Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in Preclinical Species and HumansS
Jurva, Ulrik
Weidolf, Lars
Sandinge, Ann-Sofie
Leandersson, Carina
Ekdahl, Anja
Li, Xue-Qing
Antonsson, Thomas
Sundell, Johan
Westerlund, Kristina
Amilon, Carl
Inghardt, Tord
Gopaul, V. Sashi
DRUG METABOLISM AND DISPOSITION, 2023, 51 (04) : 464 - 479
[49] Evaluation of fruquintinib, a potent and selective oral VEGFR inhibitor, in combination with targeted therapies or immune checkpoint inhibitors in preclinical tumor models
Ren, Yongxin
Sun, Qiaoling
Long, Jingwen
Fan, Shiming
Tang, Renxiang
Zhang, Wei
Ge, Xuelei
Tang, Jianxing
Wang, Linfang
Shi, Dongxia
Chen, Hongbo
Cheng, Min
Qing, Weiguo
Su, Weiguo
CANCER RESEARCH, 2017, 77
[50] Discovery of AZD5363, an orally bioavailable, potent ATP-competitive inhibitor of AKT kinases
Luke, Richard W.
Addie, Matthew
Box, Matthew R.
Buttar, David
Crafter, Claire
Currie, Gordon S.
Cosulich, Sabina C.
Davies, Barry
Dudley, Philippa G.
Greenwood, Ryan
Johnson, Paul D.
Greenwood, Hannah
Lamont, Gillian M.
Lane, Clare
Page, Ken M.
Pearson, Stuart E.
Ruston, Linette
CANCER RESEARCH, 2011, 71

← 1 2 3 4 5 →